The Faculty and Student Scholarship section is provided as a service to the WSU College of Pharmacy and Pharmaceutical Sciences community for sharing publications, presentations, and other highly transactional types of information. Accuracy of the information presented is the responsibility of those who submitted it. Submissions are reviewed for compliance with state statutes and ethics guidelines but are not edited for spelling, grammar, or clarity. Submission for Pharmaceutical Sciences faculty and PhD students can be directed to Kami Ryplewski and submissions for Pharmacotherapy faculty and Doctor of Pharmacy students to Leslie Plum.
FACULTY SCHOLARSHIP
Publications
USTUR Assistant Professor Martin Šefl, USTUR Associate Professor Maia Avtandilashvili, USTUR Director and Professor Sergei Tolmachev and one co-author published, “Latent bone modelling for estimation of plutonium concentration in skeleton of former nuclear workers”, in Radiation Protection Dosimetry, a peer-reviewed scientific journal; May 24, 2023. 199 (8-9):681-688. doi:10.1093/rpd/ncad069
Indira Mohanty (College of Veterinary Medicine graduate student, Bose Lab), Pharmaceutical Sciences Postdoctoral Research Associate Charles Mariasoosai , College of Veterinary Medicine, Director of Gene Editing Reagent Core Assistant Professor Lisette Maddison, Pharmaceutical Sciences Associate Professor Senthil Natesan, College of Veterinary Medicine, Veterinary Microbiology & Pathology Professor Santanu Bose and two co-authors published “Human beta defensin-3 mediated activation of b-catenin during human respiratory syncytial virus infection: interaction of HBD3 with LDL receptor related protein 5,” in Frontiers in Microbiology, a peer-reviewed scientific journal; June 22, 2023. https://doi.org/10.3389/fmicb.2023.1186510
Jeevan B. Gc (former Postdoctoral Research Associate, Natesan lab), Justin Chen (Pharm.D. Graduate, Honors Student Natesan Lab), Indira Mohanty, Charles Mariasoosai, Peter Obi (graduate student, Natesan lab), Paul Panipinto (graduate student, Ahmed lab), Santanu Bose, Senthil Natesan, and two co-authors published “Molecular basis for the recognition of 24-(S)-hydroxycholesterol by integrin αvβ3,” in Scientific Reports, a peer-reviewed scientific journal; June 6, 2023. https://doi.org/10.10038/s41598-023-36040-4
Jeevan B. GC, Christopher T. Szlenk (PhD. Graduate 2022), Ayobami Diyaolu (graduate student, Natesan lab), Peter Obi, Michael Gibson (retired Professor, Pharmacotherapy), Senthil Natesan, Jean-Baptiste Roullet (CPPS Research Affiliate Faculty), and two co-authors published “Allosteric modulation of GABAA receptor by Farnesol,” in Biophysical Journal, a peer-reviewed scientific journal; March 7, 2023. https://doi.org/10.1016/j.bpj.2023.01.032
Bowers, D. R., Rabourne, D. N., & McKeirnan, K. C. (2023). Impact of practice quizzes on student perceptions and assessment outcomes of a third-year pharmacotherapy course. Pharmacy Education, 23(1), p. 329–338. https://doi.org/10.46542/pe.2023.231.329338
Neumiller JJ and 2 coauthors. Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease. Curr Opin Nephrol Hypertens. 2023 May 5. Doi: 10.1097/MNH.0000000000000894. Online ahead of print.
Neumiller JJ and 3 coauthors. Optimizing multidisciplinary care of patients with chronic kidney disease and type 2 diabetes mellitus. Diabetes Ther. 2023 May 20. Doi: 10.1007/s13300-023-01416-2. Online head of print.
McKeirnan KC and Hanson, E. A qualitative evaluation of pharmacy technician opinions about administering immunizations. ELSEVIER. 2023 June. https://doi.org/10.1016/j.rcsop.2023.100280
Baker DE. Daprodustat. Hospital Pharmacy. 2023; Epub May 17, 2023 doi.org/10.1177/00185787231172382.
Kessel BA, Baker DE. Drug Evaluation – Nadofaragene firadenovec (Adstiladrin). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. April 2023.
Kessel BA, Baker DE and 1 coauthor. Drug Evaluation – Mosunetuzumab (Lunsumio) In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. April 2023.
Kessel BA, Baker DE. Drug Evaluation – Elacestrant (Orserdu). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. April 2023.
Baker DE. Drug Evaluation – Daprodustat (Jesduvroq): Updated Evaluation: In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. April 2023.
Kessel BA, Baker DE. Drug Evaluation – Olutasidenib (Rezlidhia). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. April 2023.
Baker DE. Drug Utilization Evaluation – Daprodustat (Jesduvroq). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Clinical Drug Information, LLC. April 2023.
Kessel BA, Baker DE and 1 coauthor. Drug Evaluation – Ublituximab (Briumvi): In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. May 2023.
Kessel BA, Baker DE and 1 coauthor. Drug Evaluation – Anacaulase (NexoBrid). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. May 2023.
Kessel BA, Baker DE. Drug Evaluation – Pegcetacoplan (Syforve). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. May 2023.
Levien TL, Baker DE. Drug Evaluation – Bexagliflozin (Brenzavvy). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. May 2023.
Levien TL, Baker DE. Drug Evaluation – Lecanernab (Leqembi). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. May 2023.
Baker DE. Drug Utilization Evaluation – Bexagliflozin (Brenzavvy). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Clinical Drug Information, LLC. May 2023.
Neumiller JJ and 2 coauthors. Pharmacological Management: Noninsulin Glucose-Lowering Therapies. American Diabetes Association (ADA) Diabetes is Primary CE Certificate Program 2023. Available at: https://professional.diabetes.org/diabetes-primary
Neumiller JJ and 3 coauthors. Insulin Therapy. American Diabetes Association (ADA) Diabetes is Primary CE Certificate Program 2023. Available at: https://professional.diabetes.org/diabetes-primary
Neumiller JJ. Practical insulin: A handbook for prescribing providers. 6th Ed. American Diabetes Association. 2023.
Neumiller JJ and 10 coauthors. Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD registry, 2019-2020. Diabetes Obes Metab 2023 Jul 3. Online ahead of print.
Neumiller JJ and 1 coauthor. New paradigms for CKD management in patients with T2D. J Fam Pract. 2023;72(6 Suppl):S37-S42.
Neumiller JJ and 1 coauthor. Optimized management of cardio-renal-metabolic (CRM) conditions in patients with T2D. J Fam Pract. 2023;72(6 Suppl):S43-S48.
White J. Editor. 2023–24 guide to medication’s for the treatment of diabetes mellitus. American diabetes association.
The 2023-24 Guide to Medications for the Treatment of Diabetes Mellitus is a complete and newly revised reference for every physician, clinician, and educator treating people with diabetes. Compiled and edited by a team of noted pharmacology experts specializing in diabetes care, this guide covers all aspects of diabetes drug classes including insulins, biguanides, thiazolidinediones, sulfonylureas, glinides, SGLT2 inhibitors, α-glucosidase inhibitors, DPP-4 inhibitors, GLP-1 RAs, pramlintide, bile acid sequestrants, and dopamine-2 RAs. Chapters cover the management of hyperglycemia in type 1 diabetes and an overview of medications used to treat type 2 diabetes.
McKeirnan, K. C., Kherghehpoush, S., Vaitla, K., Crutchley, R. D., & Gladchuk, A. (2023). Evaluating student pharmacist knowledge, attitudes, and confidence in caring for paediatric patients with HIV. Pharmacy Education, 23(1), p. 368–375. https://doi.org/10.46542/pe.2023.231.368375
Presentations
Dilip Kumar Singh (Associate Director of Proteomics/Metabolomics Service Center, Postdoctoral Research Associate, Prasad lab), presented a poster entitled, “High-Resolution Mass Spectrometry Coupled with XCMS Online for High-throughput Detection and Identification of Drug Metabolites”, in the postdoctoral category at the American Society for Pharmacology and Experimental Therapeutics (ASPET) meeting in St. Louis, MO; May 18, 2023.
The Meier lab presented a poster titled: Roles for CCN proteins in lysophosphatidic acid signaling in prostate cancer cells, at the World Congress of Basic and Clinical Pharmacology, WCP 2023 in Glasgow, Scotland; July 4, 2023. The authors were Pravita Balijepalli (graduate student, Meier lab) and Pharmaceutical Sciences Interim Chair and Professor Kathryn Meier.
Josh Neumiller served as faculty for the module “Shared Decision Making: Key to High-Quality CKD Care” within the Experts at Your Fingertips CME program titled: A Team Effort – Multidisciplinary Management of Chronic Kidney Disease. The program can be accessed at: https://suiteweb.atpointofcare.com/#paneldiscussion/2556
Neumiller JJ and one co-presenter. Simplify and deprescribe: when less is more for older adults with diabetes. Presented at the 2023 Annual Meeting of the Association for Diabetes Care and Education Specialist (ADCES). August 7, 2023. Houston, TX.
Service
Josh Neumiller served as faculty for the module “CKD Treatment: Addressing Kidney and Cardiometabolic Outcomes Part 3: GLP1 Receptor Agonists” for the Advancing Kidney Health Through Optimal Medication Management (AKHOMM) Slowing Kidney Disease Progression Course. The course is available at: https://kidneymedicationmanagement.nexusipe.org/continuing-education
Dana Bowers received commendations from the AACP Series Editors of the Infectious Diseases Self-Assessment Program for her work completed towards the publication of the home-study series for infectious diseases pharmacotherapy specialists.
John White was featured in an article and video by Scripps News on June 19, 2023. https://scrippsnews.com/stories/supplement-found-in-energy-drinks-may-slow-aging-study-finds/
Russ Crutchley and WSU CPPS students were featured in an article by the University of the Western Cape on June 16, 2023. https://www.uwc.ac.za/news-and-announcements/news/uwc-community-project-acquaints-us-youth-to-sa-healthcare
Russ Crutchley and WSU CPPS students were featured in an article by the University of the Western Cape on June 15, 2023. https://www.uwc.ac.za/news-and-announcements/news/youth-month-visiting-us-students-learn-about-sa-healthcare-system
Jennifer Miller was selected as a participant for the Ciphers Education Scholars Program 2023-24
Awards
Dilip Kumar Singh was honored with the first-place award for the best poster presentation in the post-doctorate category by Division of Drug Metabolism and Disposition at the American Society for Pharmacology and Experimental Therapeutics (ASPET) meeting in St. Louis, held from May 18-21, 2023. The ASPET Annual Meeting was primarily focused on facilitating the sharing of cutting-edge knowledge and innovative scientific discoveries in the fields of pharmacology and experimental therapeutics. The DMDD group within the conference encompasses extensive research on various aspects of drug disposition, metabolism, and transport, ranging from molecular mechanisms to phenotypic effects, employing both in vitro and in vivo approaches.
Dilip presented a novel high-throughput metabolomics-based MetID workflow for detection and identification of biotransformation products of drugs in biological samples. This novel approach will be useful during drug development to generate xenobiotic metabolite libraries to facilitate drug metabolism research.
Each year, the Division of Drug Metabolism and Disposition of ASPET invites the 1st place winners to serve as an Executive Committee (EC) member. Dilip Kumar Singh has been selected to represent postdoctoral fellows on the DMDD EC; July 1, 2023 – June 30, 2024.
STUDENT ACHIEVEMENT
Pharmaceutical Sciences and Molecular Medicine students
Jeevan B. Gc, Justin Chen (Pharm.D. Graduate, Honors Student Natesan Lab), Indira Mohanty, Charles Mariasoosai, Peter Obi (graduate student, Natesan lab), Paul Panipinto (graduate student, Ahmed lab), Santanu Bose, Senthil Natesan, and two co-authors published “Molecular basis for the recognition of 24-(S)-hydroxycholesterol by integrin αvβ3,” in Scientific Reports, a peer-reviewed scientific journal; June 6, 2023. https://doi.org/10.10038/s41598-023-36040-4
Jeevan B. GC, Christopher T. Szlenk (PhD. Graduate 2022), Ayobami Diyaolu (graduate student, Natesan lab), Peter Obi, Michael Gibson, Senthil Natesan, Jean-Baptiste Roullet, and two co-authors published “Allosteric modulation of GABAA receptor by Farnesol,” in Biophysical Journal, a peer-reviewed scientific journal; March 7, 2023. https://doi.org/10.1016/j.bpj.2023.01.032
Peter Obi gave an invited talk, “Deep Learning in GPCR drug discovery: Exploring novel conformational states of class A GPCRs using generative models and enhanced sampling techniques, at the Pfizer Pharmacokinetics, Dynamics, and Metabolism (PDM) Connect event (May 16, 2023) in Groton, CT.
Anoud Ailabouni (graduate student, Prasad lab) presented a poster and podium talk entitled, “Identification of endogenous biomarkers of renal organic cation transporters in rats by global metabolomics analysis”, in the graduate student category at the American Society for Pharmacology and Experimental Therapeutics (ASPET) meeting in St. Louis, MO; May 19 & 20, 2023.
Anoud Ailabouni was granted a travel award to attend the American Society for Pharmacology and Experimental Therapeutics (ASPET) meeting in St. Louis, held from May 18-21, 2023. ASPET is a scientific society that focuses on pharmacology and experimental therapeutics, covering a wide range of topics related to drug discovery and development, drug disposition, metabolism, and transport, utilizing both in vitro and in vivo methodologies. The ASPET Annual Meeting brings together researchers, scientists, academicians, and industry professionals from around the world to share and discuss the latest advancements and research in the field of pharmacology. The meeting serves as a platform for exchanging knowledge, fostering collaborations, and promoting scientific advancements in pharmacology and experimental therapeutics.
At the event, she participated in a poster competition in the graduate student category organized by the Division of Drug Metabolism and Disposition and was selected to present her work through a podium talk. During her presentation, Anoud introduced a novel untargeted metabolomics approach aimed to identify endogenous biomarkers for the organic cation transporter 2 (OCT2) expressed in rat kidneys. This research will be valuable in the early stages of drug development, as it aids in predicting renal drug-drug interactions by using novel endogenous metabolites of OCT2 that can serve as potential biomarkers.
Laken Kruger (PhD graduate 2023, Prasad Lab) was selected as the Drug Metabolism and Disposition Highlighted Trainee Author for August 2023
Doctor of Pharmacy students
Tiffany Ishibashi (Class of 2024), Allison Rembert (Class of 2024), Cheyenne Frazier, Joshua J. Neumiller. Continuous Glucose Monitor (CGM) and Blood Glucose Monitoring (BGM) Experience: Lessons Learned by Student Pharmacists. 2023 Northwest Pharmacy Convention. Coeur d’ Alene, ID. June 2, 2023.
Bahar Adamzadeh and 9 co-authors’ project, “Improving Osteoporosis Preventative Screenings and Medication Management for Women Veterans Through Advanced Pharmacy Practice,” has been selected as a VHA semifinalist at the VHA SharkTank competition